The Food and Drug Administration (FDA) is revolutionizing its import operations starting August 4 with the launch of the Nationalized Entry Review Program (NER), transitioning from a port-specific model to a centralized, nationwide approach.
The initiative is designed to streamline reviews, improve operational efficiency, and enhance collaboration across multiple time zones.